Medical Advocates
Tenofovir 300mg/Emtricitabine 200mg (Truvada)
 
Journal Citations

HIV Indications
HBV Indications
HIV/HBV Coinfection Indications




 

  
Truvada Main Page Main New/Newsworthy Home Page      

Last Update:  June 06, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
HIV Indications
     
 
A WEEK IN REVIEW FEATURED REPORT
Impact of Switching Virologically Suppressed, HIV-1-Infected Patients from Twice-Daily Fixed-Dose
Zidovudine/Lamivudine to Once-Daily Fixed-Dose Tenofovir Disoproxil Fumarate/Emtricitabine.
Wright D, Rodriguez A, Godofsky E,et al
HIV Clin Trials. 2008 Mar-Apr;9(2):103-14.
 Abstract
 
Cost-effectiveness analysis of emtricitabine/tenofovir versus lamivudine/zidovudine, in
combination with efavirenz, in antiretroviral-naive, HIV-1-infected patients.
Sánchez-de la Rosa R, Herrera L, Moreno S.
Clin Ther. 2008 Feb;30(2):372-81.
 Abstract
 
Recent Availability of Two Novel, Fixed Formulations of Antiretroviral Nucleoside Analogues:
A 12-Month Prospective, Open-Label Survey of Their Practical Use and Therapeutic Perspectives
in Antiretroviral-Naive and -Experienced Patients.
Manfredi R, Calza L.
AIDS Patient Care STDS. 2008 Feb 21
Abstract
 
FULL TEXT ARTICLE
Review of tenofovir-emtricitabine.
Masho SW, Wang CL, Nixon DE.
Ther Clin Risk Manag. 2007 Dec;3(6):1097-104.
 Paper
 
Tenofovir DF Plus Lamivudine or Emtricitabine for Nonoccupational Postexposure
Prophylaxis (NPEP) in a Boston Community Health Center.
Mayer KH, Mimiaga MJ, Cohen D,et al
J Acquir Immune Defic Syndr. 2007 Dec 20
 Abstract
 
Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine
and Efavirenz in Treatment-Naive Patients: 144-Week Analysis.
Arribas JR, Pozniak AL, Gallant JE
J Acquir Immune Defic Syndr. 2007 Oct 25;
 Abstract
 
Characterization of a novel drug-resistance pattern associated with the mutations K70G and
M184V in HIV-1 reverse transcriptase.
Bradshaw D, Malik S, Booth C, et al
Antimicrob Agents Chemother. 2007 Sep 17;
 Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
Bone disease and pathologic fractures in a patient with tenofovir-induced Fanconi syndrome.
Brim NM, Cu-Uvin S, Hu SL, O'Bell JW.
AIDS Read. 2007 Jun;17(6):322-8, C3.
 Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Versus Fixed-Dose Zidovudine/
Lamivudine and Efavirenz in Antiretroviral-Naive Patients: Virologic, Immunologic, and
Morphologic Changes: A 96-Week Analysis.
Pozniak AL, Gallant JE, Dejesus E, et al  
J Acquir Immune Defic Syndr. 2006 Oct 12;
 Abstract
 
Tenofovir disoproxil fumarate-emtricitabine coformulation for once-daily dual NRTI backbone.
Munoz de Benito RM, Arribas Lopez JR.
Expert Rev Anti Infect Ther. 2006 Aug;4(4):523-535.
 Abstract
 
In Vitro HIV-1 Resistance Selections with Combinations of Tenofovir and Emtricitabine or Abacavir
and Lamivudine.
 Margot NA, Waters JM, Miller MD.  
Antimicrob Agents Chemother. 2006 Sep 18;
 Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
 Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patients.
Gazzard BG.
Expert Opin Pharmacother. 2006 Apr;7(6):793-802
 Abstract
 
Two-once-daily fixed-dose NRTI combinations for HIV.
[No authors listed]  
Med Lett Drugs Ther. 2005 Feb 28;47(1203):19-20
 Abstract
 
Emtricitabine/tenofovir disoproxil fumarate.
 Dando TM, Wagstaff AJ.
 Drugs. 2004;64(18):2075-82;
Abstract
HBV Indications
     
  Effect of switching to tenofovir with emtricitabine in patients with chronic hepatitis B failing to
respond to an adefovir-containing regimen.
Santos SA, Uriel AJ, Park JS, et al  
Eur J Gastroenterol Hepatol. 2006 Dec;18(12):1247-53.
 Abstract
HIV/HBV Coinfection
     
  A WEEK-IN-REVIEW FEATURED REPORT
 Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with
HIV/hepatitis B virus co-infection.
 Nüesch R, Ananworanich J, Srasuebkul P, et al 
AIDS. 2008 Jan 2;22(1):152-4.
 Abstract

 

Truvada Main Page Main New/Newsworthy Home Page      

Tenofovir Disoproxil Fumarate/Emtricitabine  (Truvada)
Journal Citations